Dial For Men Dandruff Control Hair and Body Wash
- Manufacturer
- The Dial Corporation | Diversapack of Monroe
- Effective date
- 2011-01-24
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 12
- Source
- full-release
- Hydrated at
- 2026-05-31 22:27:21
Label at a glance#
Contacts and useful links#
Label contents#
Full prescribing information#
OTC - ACTIVE INGREDIENT SECTION
Active Ingredient - Pyrithione Zinc 0.95%
OTC - PURPOSE SECTION
Advanced Pyrithione Zinc formula provides a head-to-toe clean.
Helps prevent flakes and relieves scalp itch,dryness, and irritation.
INDICATIONS & USAGE SECTION
WARNINGS SECTION
Warnings For external use only
OTC - WHEN USING SECTION
When using this product avoid contact with eyes. If contact occurs,rinse eyes thoroughly with water.
OTC - ASK DOCTOR SECTION
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
DOSAGE & ADMINISTRATION SECTION
Directions
- For best results use at least twice a week or as directed by a doctor.
- Wet hair and body, massage on to scalp and affected areas in place of your regular soap or body wash,rinse,and repeat if desired.
INACTIVE INGREDIENT SECTION
Inactive ingredients WATER SODIUM LAURETH SULFATE,COCAMIDOPROPYL BETAINE,ACRYLATES COPOLYMER,GLYCERIN, FRAGRANCE,PEG-7 GLYCERYL COCOATE, POLYQUATERNIUM-7,SODIUM POLYNAPHTHALENESULFONATE,CELLULOSE GUM,SODIUM HYDROXIDE,DMDM HYDANTOIN,SODIUM CHLORIDE,CITRIC ACID,BLUE 1,YELLOW5.
OTC - QUESTIONS SECTION
Questions? 1-800-258-DIAL(3425)
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | SPL version |
|---|---|---|---|
| 1091092 | Dial Dandruff Control Hair and Body 0.95 % Medicated Shampoo | PSN | 12 |
| 1091088 | zinc pyrithione 0.95 % Medicated Shampoo | PSN | 12 |
| 1091092 | zinc pyrithione 9.5 MG/ML Medicated Shampoo [Dial Dandruff Control] | SBD | 12 |
| 1091088 | zinc pyrithione 9.5 MG/ML Medicated Shampoo | SCD | 12 |
| 1091092 | Dial Dandruff Control 9.5 MG/ML Medicated Shampoo | SY | 12 |
| 1091092 | Dial Dandruff Control Hair and Body Wash 0.95 % Medicated Shampoo | SY | 12 |
| 1091088 | zinc pyrithione 0.95 % Medicated Shampoo | SY | 12 |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 54340-003-06 | 2019-10-29 | C162847 | 48780-1 | 960f7f55-d1ba-8e05-e053-dbdaa90a074a | Drug Facts |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 54340-003-06 | Dial For Men Dandruff Control Hair and Body Wash | 6 in 1 BOX | SOLUTION | 6 | 12 | |
| 54340-003-16 | Dial For Men Dandruff Control Hair and Body Wash | 487 g in 1 BOTTLE, PLASTIC | SOLUTION | 487 | 12 | |
| 54340-003-21 | Dial For Men Dandruff Control Hair and Body Wash | 640 g in 1 BOTTLE, PLASTIC | SOLUTION | 640 | 12 |
DailyMed Dashboard NDC Coverage#
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| Pyrithione Zinc | ACTIVE INGREDIENT | R953O2RHZ5 | 12 | |
| Pyrithione Zinc | ACTIVE MOIETY | R953O2RHZ5 | 12 | |
| Carbomer 1342 | INACTIVE INGREDIENT | 809Y72KV36 | 12 | |
| Carboxymethylcellulose Sodium | INACTIVE INGREDIENT | K679OBS311 | 12 | |
| Cocamidopropyl Betaine | INACTIVE INGREDIENT | 5OCF3O11KX | 12 | |
| DMDM Hydantoin | INACTIVE INGREDIENT | BYR0546TOW | 12 | |
| Glycerin | INACTIVE INGREDIENT | PDC6A3C0OX | 12 | |
| Laureth-7 | INACTIVE INGREDIENT | Z95S6G8201 | 12 | |
| Sodium Chloride | INACTIVE INGREDIENT | 451W47IQ8X | 12 | |
| Sodium Hydroxide | INACTIVE INGREDIENT | 55X04QC32I | 12 | |
| Sodium Laureth Sulfate | INACTIVE INGREDIENT | BPV390UAP0 | 12 | |
| Water | INACTIVE INGREDIENT | 059QF0KO0R | 12 |
Products#
Every source-derived product name is available through these pages.
- Dial For Men Dandruff Control Hair and Body Wash
- Pyrithione Zinc
- Water
- Sodium Laureth Sulfate
- Cocamidopropyl Betaine
- Carbomer 1342
- Glycerin
- Laureth-7
- Carboxymethylcellulose Sodium
- Sodium Hydroxide
- DMDM Hydantoin
- Sodium Chloride
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 54340-003 | 54340-003-16, 54340-003-06, 54340-003-21 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| Pyrithione Zinc | R953O2RHZ5 | ACTIM |
| Water | 059QF0KO0R | IACT |
| Sodium Laureth Sulfate | BPV390UAP0 | IACT |
| Cocamidopropyl Betaine | 5OCF3O11KX | IACT |
| Carbomer 1342 | 809Y72KV36 | IACT |
| Glycerin | PDC6A3C0OX | IACT |
| Laureth-7 | Z95S6G8201 | IACT |
| Carboxymethylcellulose Sodium | K679OBS311 | IACT |
| Sodium Hydroxide | 55X04QC32I | IACT |
| DMDM Hydantoin | BYR0546TOW | IACT |
| Sodium Chloride | 451W47IQ8X | IACT |
Source Document#
Inactive ingredient matches#
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| Carboxymethylcellulose Sodium | CARBOXYMETHYLCELLULOSE SODIUM | K679OBS311 | FILM, SOLUBLE / BUCCAL | 47 mg | ||
| Sodium Hydroxide | SODIUM HYDROXIDE | 55X04QC32I | LIQUID / TOPICAL | ADJ PH | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SUSPENSION, EXTENDED RELEASE / ORAL | 2000 mg | ||
| Sodium Hydroxide | SODIUM HYDROXIDE | 55X04QC32I | SOLUTION / SUBCUTANEOUS | ADJ PH | ||
| Sodium Hydroxide | SODIUM HYDROXIDE | 55X04QC32I | SUSPENSION/ DROPS / TOPICAL | ADJ PH | ||
| Sodium Hydroxide | SODIUM HYDROXIDE | 55X04QC32I | INJECTION / INTRAMUSCULAR | 176 mg | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, SOLUTION, CONCENTRATE / INTRAMUSCULAR | 0.86 %w/v | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | GUM, CHEWING / BUCCAL | 230 mg | ||
| Sodium Hydroxide | SODIUM HYDROXIDE | 55X04QC32I | INJECTION, POWDER, FOR SOLUTION / INTRADISCAL | ADJ PH | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | POWDER / RESPIRATORY (INHALATION) | NA | ||
| Sodium Hydroxide | SODIUM HYDROXIDE | 55X04QC32I | TABLET, FILM COATED / ORAL | 8 mg | ||
| Sodium Hydroxide | SODIUM HYDROXIDE | 55X04QC32I | INJECTION, SOLUTION / INTRAVENOUS | 78 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | GEL / OPHTHALMIC | 0.88 %w/w | ||
| Sodium Hydroxide | SODIUM HYDROXIDE | 55X04QC32I | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAMUSCULAR | 0.35 %w/v | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, SUSPENSION, EXTENDED RELEASE / INTRAMUSCULAR | 24 mg | ||
| Sodium Hydroxide | SODIUM HYDROXIDE | 55X04QC32I | MOUTHWASH / BUCCAL | 2 mg/1ml | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | SOLUTION / IONTOPHORESIS | 0.6 %w/v | ||
| Carboxymethylcellulose Sodium | CARBOXYMETHYLCELLULOSE SODIUM | K679OBS311 | INJECTION, POWDER, FOR SUSPENSION / INTRAMUSCULAR | 25 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | DROPS / NASAL | 10 mg/1ml | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | CAPSULE, LIQUID FILLED / ORAL | 185 mg | ||
| Sodium Hydroxide | SODIUM HYDROXIDE | 55X04QC32I | INJECTION / INTRABURSAL | ADJ PH | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, POWDER, FOR SOLUTION / INTRAPLEURAL | 226 mg | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, SUSPENSION, LIPOSOMAL / EPIDURAL | 11 mg | ||
| Sodium Hydroxide | SODIUM HYDROXIDE | 55X04QC32I | CAPSULE, DELAYED RELEASE / ORAL | 0.25 mg | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | INJECTION / INTRASYNOVIAL | 0.9 %w/v | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | SOLUTION / NASAL | 330 mg | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, SOLUTION, CONCENTRATE / INTRAVENOUS | 0.86 %w/v | ||
| Sodium Hydroxide | SODIUM HYDROXIDE | 55X04QC32I | SPONGE / TOPICAL | ADJ PH | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | EMULSION / INTRAVENOUS | 2.2 %w/v | ||
| Sodium Hydroxide | SODIUM HYDROXIDE | 55X04QC32I | SOLUTION / INTRAVENOUS | 2.78 %w/v | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, SOLUTION / SUBMUCOSAL | 16 %w/v | ||
| Sodium Hydroxide | SODIUM HYDROXIDE | 55X04QC32I | INJECTION, POWDER, FOR SUSPENSION / INTRAVENOUS | ADJ PH | ||
| Carboxymethylcellulose Sodium | CARBOXYMETHYLCELLULOSE SODIUM | K679OBS311 | TABLET, FILM COATED, EXTENDED RELEASE / ORAL | 100 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | FILM, EXTENDED RELEASE / TRANSDERMAL | 306.2 mg | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | SOLUTION / EPIDURAL | 0.9 %w/v | ||
| Sodium Hydroxide | SODIUM HYDROXIDE | 55X04QC32I | OINTMENT / TOPICAL | ADJ PH | ||
| Carboxymethylcellulose Sodium | CARBOXYMETHYLCELLULOSE SODIUM | K679OBS311 | TABLET, COATED / ORAL | 3.2 mg | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, SOLUTION, CONCENTRATE / INTRAOCULAR | 0.86 %w/v | ||
| Sodium Hydroxide | SODIUM HYDROXIDE | 55X04QC32I | INJECTION, SUSPENSION, EXTENDED RELEASE / INTRAMUSCULAR | 27 mg | ||
| Sodium Hydroxide | SODIUM HYDROXIDE | 55X04QC32I | PASTE / DENTAL | 0.6 %w/w | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | INJECTION / INTRAMUSCULAR | 450 mg | ||
| Sodium Hydroxide | SODIUM HYDROXIDE | 55X04QC32I | SUSPENSION, EXTENDED RELEASE / INTRASYNOVIAL | ADJ PH | ||
| Sodium Hydroxide | SODIUM HYDROXIDE | 55X04QC32I | SOLUTION / INTRAPERITONEAL | ADJ PH | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | CAPSULE, EXTENDED RELEASE / ORAL | 41 mg | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, SOLUTION / INFILTRATION | 3535 mg | ||
| Sodium Hydroxide | SODIUM HYDROXIDE | 55X04QC32I | SOLUTION / URETHRAL | ADJ PH | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | LIQUID / INTRAMUSCULAR | 17 mg | ||
| Sodium Hydroxide | SODIUM HYDROXIDE | 55X04QC32I | SOLUTION / IRRIGATION | ADJ PH | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | SOAP / TOPICAL | 1.26 %w/w | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, POWDER, FOR SOLUTION / INTRAPERITONEAL | 226 mg | ||
| Sodium Hydroxide | SODIUM HYDROXIDE | 55X04QC32I | INJECTION, SOLUTION / INFILTRATION | ADJ PH | ||
| Sodium Hydroxide | SODIUM HYDROXIDE | 55X04QC32I | INJECTION, SOLUTION / INTRA-ARTERIAL | ADJ PH | ||
| Sodium Hydroxide | SODIUM HYDROXIDE | 55X04QC32I | CAPSULE / ORAL | 60 mg | ||
| Carbomer 1342 | CARBOMER COPOLYMER TYPE B (ALLYL PENTAERYTHRITOL CROSSLINKED) | 809Y72KV36 | EMULSION / OPHTHALMIC | 0.05 %w/w | ||
| Sodium Hydroxide | SODIUM HYDROXIDE | 55X04QC32I | INJECTION, SUSPENSION / INTRAVENOUS | ADJ PH | ||
| Sodium Hydroxide | SODIUM HYDROXIDE | 55X04QC32I | POWDER / RESPIRATORY (INHALATION) | ADJ PH | ||
| Carboxymethylcellulose Sodium | CARBOXYMETHYLCELLULOSE SODIUM | K679OBS311 | POWDER, FOR SOLUTION / ORAL | 161 mg | ||
| Sodium Hydroxide | SODIUM HYDROXIDE | 55X04QC32I | INJECTION, SOLUTION / SUBARACHNOID | ADJ PH | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS | 225 mg | ||
| Carboxymethylcellulose Sodium | CARBOXYMETHYLCELLULOSE SODIUM | K679OBS311 | SOLUTION / ORAL | 3480 mg |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| e7bdbe0b-ad74-484e-9e4b-7718d7992a21 | 73b914a1-67dc-40c9-9fc8-e8cb17599571 | 2011-01-24 | Warnings | e7bdbe0b-ad74-484e-9e4b-7718d7992a21 73b914a1-67dc-40c9-9fc8-e8cb17599571 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.

